Insulin-like growth factor physiology and cancer risk
- 1 June 2000
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (10), 1224-1228
- https://doi.org/10.1016/s0959-8049(00)00102-7
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Transforming Growth Factor-β and Breast Cancer Risk in Women With Mammary Epithelial HyperplasiaJNCI Journal of the National Cancer Institute, 1999
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-β1 on Programmed Cell Death through a p53- and IGF-independent MechanismJournal of Biological Chemistry, 1997
- Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3.JCI Insight, 1996
- Controlling IGF-receptor function: a possible strategy for tumor therapyTrends in Biotechnology, 1996
- Estradiol and Antiestrogens Regulate a Growth Inhibitory Insulin-like Growth Factor Binding Protein 3 Autocrine Loop in Human Breast Cancer CellsPublished by Elsevier ,1996
- Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancerEuropean Journal Of Cancer, 1993
- Effect of Tamoxifen on Serum Insulinlike Growth Factor I Levels in Stage I Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1990
- Immunohistochemical detection of abnormal cell proliferation in colonic mucosa of subjects with polyps.Journal of Clinical Pathology, 1990
- Cell Proliferation in CarcinogenesisScience, 1990